 |
   |
|
|
|
|
|
- Company Profile
- History
- Highlights & Milestones
- Team
- Management Team
- John W. Hadden II
- Scott M. Freeman, MD
- Harvey J. Brandwein, PhD
- John W. Hadden, MD
- Jeffrey Hwang
- Board of Directors
- John T. Spitznagel
- John W. Hadden II
- John W. Hadden, MD
- Frank J. Loverro
- Ferid Murad, MD, PhD
- Howard H. Stevenson
- Lawrence M. Wolf
- Scientific Advisory Board
- Enrico Garaci, MD
- Allan L. Goldstein, PhD
- Frederick G. Hayden, MD, FACP
- Bernard Horowitz, PhD
- Malcolm S. Mitchell, MD
- Bruce Stillman PhD, FRS
- Steering Committee
- The Immune System and IRX-2
- IRX-2 Mechanism of Action
- Glossary
- Development Pathway
- IRX-2
- IRX-3
- IRX-4-6
- Small Molecule (MIMP)
- INSPIRE Trial
- The Immune System & the INSPIRE Trial
- Prior Trials
- Patients
- Clinical trials background
- Links to additional information
|
|
© 2009 IRX Therapeutics
|
|
|